Badr, A.M.; Alkharashi, L.A.; Sherif, I.O.; Alanteet, A.A.; Alotaibi, H.N.; Mahran, Y.F.
IL-17/Notch1/STAT3 Pathway Contributes to 5-Fluorouracil-Induced Intestinal Mucositis in Rats: Amelioration by Thymol Treatment. Pharmaceuticals 2022, 15, 1412.
https://doi.org/10.3390/ph15111412
AMA Style
Badr AM, Alkharashi LA, Sherif IO, Alanteet AA, Alotaibi HN, Mahran YF.
IL-17/Notch1/STAT3 Pathway Contributes to 5-Fluorouracil-Induced Intestinal Mucositis in Rats: Amelioration by Thymol Treatment. Pharmaceuticals. 2022; 15(11):1412.
https://doi.org/10.3390/ph15111412
Chicago/Turabian Style
Badr, Amira M., Layla A. Alkharashi, Iman O. Sherif, Alaa A. Alanteet, Hind N. Alotaibi, and Yasmen F. Mahran.
2022. "IL-17/Notch1/STAT3 Pathway Contributes to 5-Fluorouracil-Induced Intestinal Mucositis in Rats: Amelioration by Thymol Treatment" Pharmaceuticals 15, no. 11: 1412.
https://doi.org/10.3390/ph15111412
APA Style
Badr, A. M., Alkharashi, L. A., Sherif, I. O., Alanteet, A. A., Alotaibi, H. N., & Mahran, Y. F.
(2022). IL-17/Notch1/STAT3 Pathway Contributes to 5-Fluorouracil-Induced Intestinal Mucositis in Rats: Amelioration by Thymol Treatment. Pharmaceuticals, 15(11), 1412.
https://doi.org/10.3390/ph15111412